Skip to main content

Advertisement

Table 5 Determinants for not increasing medication when patients have moderate/high disease activity

From: DAS steered therapy in clinical practice; cross-sectional results from the METEOR database

  DAS > 2.4: medication is not increased vs medication is increased (n = 1.574 visits)a
ß OR (95 % CI) P-value
ESRa 0.00 1.00 (0.99–1.01) 0.86
SJCa −0.02 0.99 (0.96–1.01) 0.20
VASpta 0.00 1.00 (0.99–1.01) 0.98
TJCa 0.05 1.05 (1.01–1.10) <0.01
Actual druga    
 DMARD monotherapy 1.19 3.28 (2.40–4.48) <0.01
 MTX + bDMARD 0.66 1.93 (1.25–2.98) <0.01
 DMARD combination therapy 0.12 1.12 (0.83–1.53) 0.46
 DMARD + prednisone 0.03 1.03 (0.67–1.57) 0.90
  1. aGEE binary logistic regression. Analysis is corrected for gender and age. ESR Erythrocyte Sedimentation Rate, SJC swollen joint count, TJC tender joint count, VasPtGlobal Patient Assessment of Global Disease Activity. Reference category ‘Actual drugs’ = other drugs